Integrated Chinese and Western Medicine in Treatment of Critical Coronavirus Disease (COVID-19) Patient with Endotrachea
- PDF / 172,504 Bytes
- 4 Pages / 612.284 x 824.882 pts Page_size
- 48 Downloads / 180 Views
C
hinese Journal of Integrative Medicine
•1•
Available online at link.springer.com/journal/11655 Journal homepage: www.cjim.cn/zxyjhen/zxyjhen/ch/index.aspx E-mail: [email protected]
Case Report
Integrated Chinese and Western Medicine in Treatment of Critical Coronavirus Disease (COVID-19) Patient with Endotracheal Intubation: A Case Report YAO Shun-yu1, LEI Chao-qi2, LIAO Xiang2, LIU Ru-xiu1, CHANG Xing1, and LIU Zhi-ming1 Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).(1) The disease has spread globally, resulting in the coronavirus pandemic. (2,3) Common symptoms include fever, cough, and shortness of breath. Muscle pain, sputum production and sore throat are less common.(4,5) While the majority of cases result in mild symptoms,(6,7) some progress to severe or critical pneumonia and multiorgan failure. Worldwide, there is a high mortality rate in severe or critical patients of COVID-19. (8,9) Here we report a critical case of COVID-19 patient with endotracheal intubation successfully treated with integrated Chinese and Western medicine (ICWM).
Case Presentation A 37-year old male patient was admitted to the Xiangtan Central Hospital on Jan 28, 2020 with complaint of aggravating cough for 2 months (admission No. 831991). He had a history of chronic cough. He has been coughing for at least 3 months every winter and spring for the past 10 years. The present cough was caused by a cold 2 months ago. He said that he had right chest pain when coughing, but was mostly free of phlegm, occasionally coughing up small amounts of yellowish-white thick phlegm. On Jan 28, results of reverse transcription polymerase chain reaction (rRT-PCR) to SARS-CoV-2 from nasopharyngeal swab were positive. The test results of influenza A and influenza B virus antigens were negative. The patient denied the history of hypertension, diabetes, coronary heart disease and other chronic diseases. He had lived locally for a long time and denied that he had a recent travel or living history in Hubei province, or that he had close contact with people who had fever and respiratory symptoms. So he was diagnosed as COVID-19 (suspected)
and chronic bronchitis. The main treatments and examination results of the patient are shown in Appendixes 1–8 for details. On Feb 3, the patient's condition worsened and the diagnosis was adjusted to severe COVID-19. The main symptoms and signs of the patients were fever, fatigue, poor appetite, cough, expectoration, slight shortness of breath. The tests indicated that the patient had severe acute respiratory distress syndrome (ARDS). On Feb 4, the patient's condition worsened further and the diagnosis was adjusted to critical COVID-19. Endotracheal intubation was carried out. On Feb 10, critical value reported indicated that gram-positive Cocci grew in aerobic blood culture bottle of the patient's catheter blood. Physicians removed central venous catheter. On Feb 11, the patient's tracheal intubation was removed due to infection. O
Data Loading...